chr3-190855873-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001146686.3(GMNC):āc.427T>Cā(p.Phe143Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000058 in 1,550,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001146686.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMNC | NM_001146686.3 | c.427T>C | p.Phe143Leu | missense_variant | 5/5 | ENST00000442080.6 | NP_001140158.1 | |
GMNC | XR_924161.3 | n.463+1910T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMNC | ENST00000442080.6 | c.427T>C | p.Phe143Leu | missense_variant | 5/5 | 5 | NM_001146686.3 | ENSP00000406164 | P1 | |
GMNC | ENST00000495042.1 | n.321T>C | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
GMNC | ENST00000479491.5 | n.333T>C | non_coding_transcript_exon_variant | 4/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000172 AC: 27AN: 156954Hom.: 0 AF XY: 0.000169 AC XY: 14AN XY: 83052
GnomAD4 exome AF: 0.0000572 AC: 80AN: 1398666Hom.: 0 Cov.: 30 AF XY: 0.0000696 AC XY: 48AN XY: 689936
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2022 | The c.427T>C (p.F143L) alteration is located in exon 5 (coding exon 5) of the GMNC gene. This alteration results from a T to C substitution at nucleotide position 427, causing the phenylalanine (F) at amino acid position 143 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at